A high-sensitive blood test can aid concussed hockey players when it might be safe to return to play. In a study published by the journal Neurology, researchers at Sahlgrenska Academy has identified a superior blood-based biomarker for assessing subtle brain injury.
Researchers at the University of Michigan have engineered a new compound that animal tests suggest could offer the pain-relieving properties of opioids such as morphine and oxycodone without the risk of addiction.
Findings from a new study conducted in rats reveal that females may be more susceptible to migraines and less responsive to treatment because of the way fluctuations in the hormone estrogen affect cells in the brain.
Technological advances have ushered in a new era of discovery in neuroscience. The Experimental Biology 2018 meeting (EB 2018) will feature an array of research findings on the brain and nervous system. The studies shed new light on the intricate circuitry behind our thought processes, feelings and behaviors and offer leads for both high-tech and low-tech treatment approaches.
Research into cancer can provide new insight into how this disease works and how it can be stopped. The Experimental Biology 2018 meeting (EB 2018) will showcase innovative research that could lead to new ways to treat and prevent cancer.
New research documents how chemicals and a certain gene activate an enzyme to increase the risk and severity of RA and bone destruction.
Using computer models and laboratory rats, Johns Hopkins researchers have demonstrated that 'direct electrical current' can be delivered to nerves preferentially, blocking pain signals while leaving other sensations undisturbed.
A 2014 federal change that limited the dispensing of hydrocodone products may be indirectly contributing to the illegal use of some of those drugs, a study by University of Texas Medical Branch researchers has found.
Can medical marijuana help to fight the opioid epidemic? Many believe that it can. But a new study finds that people who use medical marijuana actually have higher rates of medical and non-medical prescription drug use--including pain relievers. The study appears in the Journal of Addiction Medicine, the official journal of the American Society of Addiction Medicine (ASAM), published by Wolters Kluwer.
People who have tried unsuccessfully to prevent migraine with other treatments may find relief with a drug called erenumab, according to a preliminary study released today that will be presented at the American Academy of Neurology's 70th Annual Meeting in Los Angeles, April 21 to 27, 2018.